View Single Post
Old 08-19-2012, 01:13 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 19,989
Added Benefit Of Eribulin In Breast Cancer Is Not Proven

Eribulin (trade name: HalavenĀ®) was approved in March 2011 for women with locally advanced or metastasizing breast cancer in whom the disease has progressed despite prior drug therapy...

More...
News is offline   Reply With Quote